Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) EBT (2016 - 2025)

Historic EBT for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $474000.0.

  • Axogen's EBT rose 12477.78% to $474000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 8265.89%. This contributed to the annual value of -$10.4 million for FY2024, which is 5461.64% up from last year.
  • Per Axogen's latest filing, its EBT stood at $474000.0 for Q3 2025, which was up 12477.78% from -$80000.0 recorded in Q2 2025.
  • Axogen's 5-year EBT high stood at $541000.0 for Q4 2024, and its period low was -$11.7 million during Q1 2022.
  • In the last 5 years, Axogen's EBT had a median value of -$5.2 million in 2022 and averaged -$4.9 million.
  • Its EBT has fluctuated over the past 5 years, first plummeted by 40134.37% in 2021, then surged by 12477.78% in 2025.
  • Quarter analysis of 5 years shows Axogen's EBT stood at -$5.3 million in 2021, then rose by 1.86% to -$5.2 million in 2022, then increased by 9.09% to -$4.7 million in 2023, then soared by 111.51% to $541000.0 in 2024, then dropped by 12.38% to $474000.0 in 2025.
  • Its EBT stands at $474000.0 for Q3 2025, versus -$80000.0 for Q2 2025 and -$3.6 million for Q1 2025.